healthcare professional for medical advice
difficult urination
black tarry stool
didanosine
burn
edema
fatal case
lack
incidence of these toxicity
indigestion
depletion of mitochondrial dna
excess lactic acid leak
rechallenge
fullness
blindness
diabetes mellitus
blood in the urine
sleepiness
cardiovascular
increase rate of liver function abnormality
serum gamma glutamyltransferase
hepatic failure
stavudine with other antiretroviral agent
difficulty with sleep
rash
unusual tiredness
dry eye
increase production
neutropenia
cold sweat
loss of consciousness
factor
anemia
fatal hepatic event
serum amylase
hiv
weakness in the arm
hair loss
bruise
develop peripheral neuropathy
insomnia
flatulence
gamma glutamyltransferase
ventricular failure
chest pain
vomit
blur vision
light color stool
foot
fruit like breath odor
significant underlie liver disease
steatohepatitis
sore throat
nausea
swell of the eyelid
health care professional
clay color stool
dyspepsia
skin rash
breast enlargement
bloat
setting of immune reconstitution
autoimmune disorder
fulminant hepatitis
fast heartbeat
red spot on the skin
slurred speech
release
sour stomach
dizziness
higher incidence
lactic acidosis severe
serious concern with the use of didanosine in combination with other antiretroviral
redistribution accumulation of body fat
decrease vision
videx
symptomatology
constipation
tightness in the chest
hepatitis
substantial alcohol intake
abdominal pain
unusual bleeding
low cd
clinical course of aid
fatal lactic acidosis
pregnant woman
hyperuricemia
hive
nausea and vomit
change in the color of the eye
acid
buffer formulation
blue yellow color blindness
depression
irritability
gas in the stomach
combination with other agent with similar toxicity
other antiretroviral agent
increase urination
case of acute gouty arthritis
white spot on the lip
nightmare
decrease mitochondrial energy generate capacity
stool
didanosine in combination with stavudine
combination of hydroxyurea
combination of didanosine
underlie cardiomyopathy
acute renal failure
tingle
safety
hepatic steatosis
hydroxyurea
medicine
myopathy
ulcer
dyspnea
sialoadenitis
postmarket experience
body
fever and chill
facial waste
incidence
advanced hiv disease
leg
confusion
asthenia
discontinuation of didanosine
hemodialysis
elevated serum
didanosine while lactic acidosis
peripheral waste
develop pancreatitis
coma
convulsion seizure
cough
dorsocervical fat enlargement
active ingredient
liver function
blood ph
increase in creatine kinase
flush dry skin
restlessness
cramp
numbness
hypoglycemia
early sign of noncirrhotic portal hypertension
aid diagnosis
cell into systemic circulation
insulin resistance
increase level without acidosis
immune reconstitution syndrome
swollen gland
administer didanosine
tongue
rash pruritus
reverse transcriptase inhibitor
fda
optic neuritis
pancreatitis
case of cutaneous leukocytoclastic vasculitis
recurrent disease
hepatotoxicity
grade
peripheral visual fold reduction
liver failure
radiate
decrease clearance of didanosine
seizure
cd
swell of the foot
incidence at month for pancreatitis
pericarditis
rhabdomyolysis
diffuse dysfunction of the retinal epithelium
amylase
hyperglycemia
peripheral neurologic symptom neuropathy
anorexia
sweating
excess air
eye
dry mouth
addition
bleed gum
guillain barre syndrome
postmarket experience with hydroxyurea
symptomatic hyperlactatemia lactic acidosis
puffiness
pain in the stomach
impaired glucose tolerance
competitive inhibitor of dna polymerase
swollen joint
thin of the hair
pain in the hand
heartburn
headache
short course of indomethacin
loss of appetite
intestine
tenofovir
efficacy
decrease appetite
parotid gland enlargement
lactate elevation
unexplained weight loss
hypertriglyceridemia
back
full feeling
sore
hyperlactatemia
retinal change
accumulation of body fat
general feeling of discomfort
eap
case
leukopenia
medical attention
anxiety
loss of strength
increase hunger
belch
increase production of lactic acid
shortness of breath
pancreatitis from the virus
myalgia
orthopnea
dark urine
splenomegaly
hand
arthralgia
redistribution
difficulty with move
uric acid
steatosis
cushingoid appearance
elevated lipase
mitochondria
stomachache
lactic acidosis
didanosine related toxicity
eye pain
side
joint pain
cell count
caution
increase risk of toxicity
peripheral neuropathy
cool pale skin
sole of the foot
serum alkaline phosphatase
insulin dependent diabetes mellitus
yellow skin
develop
combination
lactic acidosis if hydrogen ion
bilirubin
difficulty with swallow
diarrhea
fast shallow breathing
alopecia
hepatic toxicity
lip
polymyositis
preexist liver dysfunction
weakness
elevated alkaline phosphatase
diffuse dysfunction of the retinal epithelium with bilateral visual deficit
nervous system
troubled breathing with exertion
unsteadiness or awkwardness
prior history
combination with other antiretroviral agent
pain
itch
stavudine
elevated liver transaminase
abdomen
severe peripheral neuropathy
greatest affinity
thrombocytopenia
mouth
diminish clearance
stomach pain
bilateral visual deficit
infrequent occurrence
increase thirst
grave
chronic active hepatitis
central obesity
disturbance in metabolic homeostasis with antiretroviral
stomach discomfort
baseline hyperamylasemia
neuropathy
night blindness
cellular respiratory function
disease
face
noncirrhotic portal hypertension
retinal depigmentation
shakiness
high sodium content
chill fever
use of nucleoside analog
lower leg
muscle
resolution
increase risk for pancreatitis
pass gas